Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma

Clinical trial NCT01315873 · TERMINATED

Trial details

NCT number: NCT01315873
Sponsor: NYU Langone Health
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2011-09-01
Primary completion: 2014-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.